Tissue Regenix Group plc (LON:TRX – Get Free Report)’s share price reached a new 52-week low on Tuesday . The stock traded as low as GBX 35 ($0.45) and last traded at GBX 35.42 ($0.46), with a volume of 27614 shares. The stock had previously closed at GBX 36.50 ($0.47).
Tissue Regenix Group Stock Down 3.0 %
The firm has a market cap of £31.93 million, a P/E ratio of -36.57 and a beta of 1.61. The firm’s 50 day moving average is GBX 50.24 and its two-hundred day moving average is GBX 55.07. The company has a current ratio of 4.03, a quick ratio of 2.36 and a debt-to-equity ratio of 31.16.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Featured Stories
- Five stocks we like better than Tissue Regenix Group
- How to Use Stock Screeners to Find Stocks
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- About the Markup Calculator
- NVIDIA Insiders Sell: This Is What It Means for the Market
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
